Profile: Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category.

• Lindsay Bebout
  Associate Director, Policy & Advocacy
• Stephanie Garland
  Medical Affairs Therapy Lead
• Carla Ryan, PharmD
  BCMAS, Executive Medical Science Liaison
• Larry Schneeberg
  Head of Marketing, Overdose Reversal Science